Author: Xenetic Biosciences, Inc.

Posted Date:

May 13, 2026

Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform

Xenetic Biosciences, Inc.

May 13, 2026
Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting

Xenetic Biosciences, Inc.

April 22, 2026
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results

Xenetic Biosciences, Inc.

March 13, 2026